Abstract:While our understanding of the developmental biology of the skeleton, like that of virtually every other subject in biology, has been transformed by recent advances in human and mouse genetics, we still know very little, in molecular and genetic terms, about skeletal physiology. Thus, among the many questions that are largely unexplained are the following: why is osteoporosis mainly a women's disease? How is bone mass maintained nearly constant between the end of puberty and the arrest of gonadal functions? Molecular genetics has emerged as a powerful tool to study previously unexplored aspects of the physiology of the skeleton. Among mammals, mice are the most promising animals for this experimental work. This has been previously demonstrated e.g. through the tremendous impact of the different osteopetrotic models on our molecular understanding of osteoclastic bone resorption. Until recently the only way of studying bone loss situations and osteoporosis in mice was by using ovariectomy with all its limitations. Today, however, we have access to more sophisticated osteoporotic mouse-models from four different origins: Transgenic mice (HSV-TK), knock-out mice (OPG), inbred-strains (SAMP6), and through physiological modulation (icv application). These new models have already taught us several important lessons. The first is, that bone remodeling is more than just an autocrine/paracrine process. Multiple experimental evidence has demonstrated that the latter regulation exists, but genetics prove that there is no functional cross-control between resorption and formation. The second lesson is, that remodeling is, at least in part, subject to central regulation. Thus, osteoporosis is partly a central or hypothalamic disease. However, the most dramatic change and the most important advantage we feel is, that today we have models to test a new hypothesis regarding the etiology of osteoporosis before it turns to dogma. Taken together, mouse-studies may lead to a shift in our physiological understanding of skeleton biology and to the emergence of novel paradigms. These, in turn, should help us to devise new treatments for degenerative diseases of the skeleton such as osteoporosis and its associated clinical problems.

The Past, Present, and Future of Genetically Engineered Mouse Models for Skeletal Biology

SEMMs: Somatically Engineered Mouse Models. A New Tool for In Vivo Disease Modeling for Basic and Translational Research

Genetically engineered mouse models in oncology research and cancer medicine

If you give a mouse a mutation: comparing the therapeutic utility of renowned mouse models of human cancers

Osteopenic mice: animal models of the aging skeleton.

Modeling Rare Bone Diseases in Animals

Mouse Cre Models for the Study of Bone Diseases

Germline Saturation Mutagenesis Induces Skeletal Phenotypes in Mice

Mouse models of ALS: Past, present and future

Genetically engineered mouse models of head and neck cancers

Transgenic mice technology and its application in bone and cartilage research

Mouse Models and Online Resources for Functional Analysis of Osteoporosis Genome-Wide Association Studies

In situ CRISPR‐Cas9 base editing for the development of genetically engineered mouse models of breast cancer

In vivo models of brain tumors: roles of genetically engineered mouse models in understanding tumor biology and use in preclinical studies

Somatic Genome-Engineered Mouse Models Using In Vivo Microinjection and Electroporation

Optimization of Xenografting Methods for Generating Human Skeletal Muscle in Mice

Xenografting Human Musculoskeletal Sarcomas in Mice, Chick Embryo, and Zebrafish: How to Boost Translational Research

Latest developments in engineered skeletal muscle tissues for drug discovery and development

[Application and Recent Advances of Laboratory Mouse in Human Cancer Research].

Preclinical Rodent Models for Human Bone Disease, Including a Focus on Cortical Bone

Screening Gene Knockout Mice for Variation in Bone Mass: Analysis by μCT and Histomorphometry